UPL Limited

UPL Limited

UPL.BO
UPL LimitedIN flagBombay Stock Exchange
601.00
INR
-7.65
- -
507.89BMarket Cap
UPL Limited
UPL.BO
(Bombay Stock Exchange)

Recent

price

601.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
81.31
104.98
128.1
154.8
178.81
174.99
203.37
215.69
271.46
445.43
482.33
577.16
679.03
556.48
502.24
602
570.91
Revenue per Share
8.3
8.24
10.49
13.81
17.07
11.86
21.78
25.44
18.72
22.3
36.04
45.52
45.62
-15.68
9.66
22.32
14.56
Basic EPS, GAAP
1.49
-5.63
24.02
12.55
8.44
4.82
16.72
17.94
9.81
84.86
63.9
47.81
68.89
4.26
91.06
63.28
- -
Free Cash Flow per Basic Share
1.25
1.27
1.62
1.6
2.55
2.69
2.67
4.49
5.11
5.11
5.75
9.59
9.58
9.78
0.83
5.55
- -
Dividend per Share
24.89
14.4
23.23
33.4
31.81
36.14
55.55
75.87
156.34
178.57
160.97
195.2
261.87
239.57
226.44
1.96
- -
Book Value per Share
34.32
31.71
36.47
45.64
53.44
52.82
70.64
93.07
-125.29
-94.23
-53.45
-1.53
53.23
19.58
67.22
79.92
- -
Tangible Book Value per Share
700
722
707
688
670
793
793
795
796
796
797
797
782
766
929
861
819
Basic Weighted Avg Shares
56,934
75,808
90,614
106,502
119,845
138,710
161,240
171,410
216,210
354,780
384,180
459,710
531,340
425,990
466,370
518,390
467,860
Sales/Revenue/Turnover
15.26
14.6
14.53
15.81
16.17
14.17
15.95
16.73
14.77
14.56
16.84
16.97
16.47
6.69
12.03
13.68
12.4
Operating Margin (%)
2,138
2,924
3,537
4,069
4,245
6,760
6,720
6,750
8,800
20,120
21,730
23,590
25,470
27,630
27,500
32,440
28,210
Depreciation Expense
5,810
5,953
7,423
9,498
11,440
9,400
17,270
20,220
14,910
17,760
28,710
36,260
35,700
-12,000
8,970
19,220
11,930
Net Income, GAAP
11
17.57
21.52
19.17
17.3
14.77
9.83
11.93
11.17
21.2
16.41
10.65
14.29
- -
1.09
29.68
21.64
Effective Tax Rate (%)
10.2
7.85
8.19
8.92
9.55
6.78
10.71
11.8
6.9
5.01
7.47
7.89
6.72
-2.82
1.92
3.71
2.55
Profit Margin (%)
17,466
26,270
32,392
29,114
29,260
30,390
66,700
73,820
104,610
125,560
104,430
117,520
129,910
124,670
110,920
75,470
- -
Working Capital
10,023
23,772
28,123
22,543
17,930
22,660
53,500
58,730
263,820
279,570
227,260
222,310
208,190
249,680
192,560
165,560
- -
LT Debt
37,440
44,230
48,794
54,195
54,050
59,330
74,300
91,880
181,710
225,930
245,800
293,080
354,290
327,060
378,260
412,690
- -
Total Equity
13.13
12.92
12.42
15.63
18.15
16.73
19.01
17.41
9.12
8.3
10.82
13.39
13.11
- -
8.93
7.79
- -
Return on Invested Capital (%)
17.79
17.27
17.68
19.89
22.56
19.27
23.63
21.49
7.63
5.63
8.08
10.01
10.9
- -
8.71
9.79
9.4
Return on Capital (%)
37.88
42.79
55.33
48.2
51.65
37.62
47.52
38.76
16.14
13.32
21.23
25.56
19.81
-6.18
4.56
18.14
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'25
Mar'25
Jun'26
ST Debt
- -
58,430
- -
LT Borrowings
- -
182,630
- -
LT Finance Leases
- -
9,930
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
844
- -
Market Capitalization
381,302
490,571
541,767

Working Capital

FRC

in mil. unless spec.
Dec'25
Mar'25
Jun'26
Total Current Assets
- -
396,610
- -
Cash, Cash Equivalents & STI
- -
99,230
- -
Accounts Receivable, Net
- -
159,940
- -
Inventories
- -
103,160
- -
Total Current Liabilities
- -
285,690
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
58,430
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
23.7%
11.44%
9.1%
Free Cash Flow
333.09%
476.15%
-35.56%
Net Income, GAAP
-1.4%
-33.87%
114.27%
Sales/Revenue/Turnover
15.71%
7.21%
11.15%
Total Cash Common Dividend
- -
99.18%
520.78%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
89,630
101,700
98,870
135,790
425,990
2025
90,670
110,900
109,070
155,730
466,370
2026
92,160
122,690
183,350
- -
518,390

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.12
-2.44
-16.91
- -
-15.68
2025
-5.9
-5.68
9.7
11.2
9.66
2026
-1.04
4.69
12.57
- -
22.32

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
9.78
2025
- -
- -
- -
- -
0.83
2026
- -
- -
- -
- -
5.55
Business
UPL Limited (UPL.BO) is an India-based global provider of sustainable agricultural solutions, including crop protection products, seeds, and digital agriculture services. The company manufactures and markets a broad portfolio of products such as insecticides, fungicides, herbicides, seed treatment products, post-harvest solutions, and biologicals under brands like UPL, Advion, and Inscalis; it also offers biosolutions, crop nutrition, and precision agriculture technologies through its Arysta LifeScience and Performix subsidiaries. Founded in 1969 and headquartered in Mumbai, India, UPL operates in over 130 countries across North America, Europe, Latin America, Asia, and Africa, serving farmers, agribusinesses, and food processors with integrated solutions for sustainable farming. In recent developments, UPL completed the acquisition of MAgN Chemicals in the US to expand its North American crop protection portfolio in 2024; formed strategic partnerships with FMC Corporation for co-developing new insecticide molecules and with Bayer for biological crop protection distribution in 2025; and launched new biosolution products targeting key crops amid a shift toward sustainable agriculture amid regulatory pressures on conventional chemistries.